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Microbes interact with the host to
influence physiology and
pathophysiology by poorly understood
mechanisms. Hickey et al. show that
Bacteroides thetaiotaomicron, a
colitogenic bacterium of the gut flora,
generates numerous bacterial antigen-
containing outer membrane vesicles that
access host immune cells in a sulfatase-
dependent manner.
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Microbes interact with the host immune system via
several potential mechanisms. One essential step for
eachmechanism is themethodbywhich intestinalmi-
crobes or their antigens access specific host immune
cells. Using genetically susceptible mice (dnKO) that
develop spontaneous, fulminant colitis, triggered by
Bacteroides thetaiotaomicron (B. theta), we investi-
gated the mechanism of intestinal microbial access
under conditions that stimulate colonic inflammation.
B. theta antigens localized to host immune cells
through outer membrane vesicles (OMVs) that harbor
bacterial sulfatase activity. We deleted the anaerobic
sulfatase maturating enzyme (anSME) from B. theta,
which is required for post-translational activation of
all B. theta sulfatase enzymes. This bacterial mutant
strain did not stimulate colitis in dnKO mice. Lastly,
access of B. theta OMVs to host immune cells was
sulfatase dependent. These data demonstrate that
bacterial OMVs and associated enzymes promote in-
flammatory immunestimulation in genetically suscep-
tible hosts.
INTRODUCTION
Host-microbial interactions play a vital role in systemic physi-
ology and pathophysiology; however, such contact, especially
in the colon, is greatly limited by host barriers. The colonic epithe-
lium provides important key barriers against a dense (1011–12
bacteria/ml) and diverse population of bacteria (Human Micro-
biome Project Consortium, 2012a, 2012b). Epithelial stem cells
at the base of the crypts of Lieberku¨hn drive rapid epithelial cell
turnover of differentiated cell lineages that include absorptive co-
lonocytes and goblet cells, which in turn form two major barriers672 Cell Host & Microbe 17, 672–680, May 13, 2015 ª2015 Elsevier I(Kuhnert et al., 2004; Lee et al., 2009). First, colonocytes migrate
and exit crypts to form a sheet of cells, creating a cellular barrier.
Overlying this layer of cells is a second barrier composed of a
stratified 50-mm inner mucus layer that lines the apical surface
of the epithelium (Johansson et al., 2008). This mucus layer acts
as a physical obstruction as bacteria cannot enter the net-like
sheaths formed by the MUC2 polymers (Ambort et al., 2012;
Johansson et al., 2013). The functions of these two epithelial-
based barriers have important reciprocal interactions with indig-
enous microbes (Kaiko and Stappenbeck, 2014).
Overall, microbes interact with the host immune system and
bypass these barriers by using several potential mechanisms.
One simple mechanism involves capture of bacteria near the
mucosal surface by host antigen presenting cells (APCs). In
the small intestine, APCs can directly engulf bacteria within
the intestinal lumen (Niess et al., 2005). Another mechanism
involves diffusion of soluble microbial antigens or products
that can be detected by the host through specific receptors
(i.e., lipopolysaccharide through TLR4) (Tannahill et al., 2013).
Lastly, bacteria, especially Gram-negative microbes, can re-
lease enzyme-containing outer membrane vesicles (OMVs) that
perform a variety of activities to benefit the parent microbe (Elhe-
nawy et al., 2014; Ellis and Kuehn, 2010; Kulp and Kuehn, 2010).
OMVs have been proposed to mediate microbial interactions
with the host (Shen et al., 2012), though the mechanisms by
which they traverse host barriers are unclear.
Bacteroidaceae is a prominent family of intestinal symbiotic
organisms. The extent to which these diverse organisms influ-
ence host physiology and disease models is unclear beyond a
few examples (Bloom et al., 2011; Housseau and Sears, 2010;
Shen et al., 2012), and precise mechanisms are still elusive.
One member of this family, Bacteroides thetaiotaomicron
(B. theta), is fully sequenced, genetically manipulable, and has
a well-defined role in complex carbohydrate metabolism, in-
cluding interactions with host mucin glycans (Benjdia et al.,
2011; Martens et al., 2008; Sonnenburg et al., 2005). These char-
acteristics make B. theta an appropriate experimental model to
elucidate both beneficial and detrimental host interactionsnc.
Figure 1. Extracellular Bacterial Antigen
from WT B. theta Localizes to the Host
Peri-Cryptal Mesenchyme in dnKO Mice
(A and B) Specificity of (A) 3H2 and (B) 6E9
antibody to different Bacteroides species
(B. uniformis, B. vulgatus, B. TP5, B. theta)
measured via ELISA at OD of 450 nm at increasing
doses of antibody ± SEM. Controls include (A)
acapsular B. theta mutant and (A and B) E. coli.
(C) Cartoon of the mouse colon indicating the
location of images in (D–G). (D) and (E), lumen; (F)
and (G), mucosa.
(D–G) Sections of the colonic lumen (D and E) and
mucosa (F and G) from dnKO mice 3 weeks after
gavage with WT B. theta stained with 3H2 conju-
gated to Alexa 647 (D and F) and 6E9 conjugated
to Alexa 594 antibodies, both in red (E and G).
DAPI indicates nuclei in blue. Bars, 3 mm (D and E).
Bars, 50 mm (F and G). See also Figure S1.amongmembers of this family. Specifically,B. theta is well suited
to interact with at least one of the barriers, the host mucin gly-
cans, because of polysaccharide utilization loci (PULs) in
B. theta’s genome that encode several mucin-degrading en-
zymes such as glycosidase hydrolases (GHs) and sulfatases
(Benjdia et al., 2011; Martens et al., 2008). Here, we used
B. theta (strains dnlkv9 and VPI-5482, thereby referred to in the
text as B. theta) in an experimental mouse model of intestinal
inflammation to decipher the mechanism by which B. theta tra-
verses host barriers and contacts the host. We have developed
a highly reproducible system, dnKO mice (CD4-dnTgfb2;
IL10rb/), in which exposure to B. theta is sufficient to trigger
disease (Bloom et al., 2011; Kang et al., 2008). In this study,Cell Host & Microbe 17, 672–we demonstrate that B. theta requires
sulfatases to cause colitis in dnKO mice,
and that B. theta OMVs gain access to
host immune cells in a sulfatase-depen-
dent manner.
RESULTS
Extracellular Antigens from WT
B. theta Localize to the Host Peri-
Cryptal Mesenchyme in dnKOMice
SinceB. theta is sufficient to trigger colitis
in dnKO mice, we first determined
B. theta’s localization with a panel of
monoclonal antibodies. Multiple clones
were reactive and specific to B. theta by
ELISA (Figures 1A and 1B), but the two
mostpromising candidateswere selected
by in situ luminal staining of intestinal tis-
sue sections from WT mice: 3H2 and
6E9. We found that 3H2 labeled the pe-
riphery of bacterial cells in colonic sec-
tions of dnKO and control (IL10rb+/)
mice that were pretreated with antibiotics
followed by gavage with WT B. theta (Fig-
ures 1C, 1D, andS1A) (Bloomet al., 2011).
Based on this staining pattern, we sur-
mised that the target of 3H2 was a highly expressed surface an-
tigen such as one of the eight capsules forB. theta (Martens et al.,
2009). We found that 3H2 recognized capsule 3 of B. theta (Fig-
ures S1B and S1C), and thereby stains a subset of whole
B. theta. However, despite the robust signal in the dnKO colonic
lumens (Figures 1C and 1D), we did not detect any staining in the
mucosa or in the lumen of crypts (Figure 1F; Figure S1D for addi-
tional controls). In contrast, 6E9 labeled abundant small particles
in the lumen that were not directly associated with Bacteroides
DNA (Figures 1C, 1E, and S1A), providing us different antibodies
to identify whole bacteria versus bacterial particles. Interestingly,
6E9-positive particleswere present inmesenchymal cells around
the crypt base of dnKO mice where inflammation is typically680, May 13, 2015 ª2015 Elsevier Inc. 673
Figure 2. Host-Penetrant B. theta Antigen
Localizes to OMVs with Sulfatase Activity
(A–C) Transmission electron microscopy (TEM)
image of cultured (A) WT or (C) DanSME B. theta
strains on grids without sectioning. Arrows, OMVs.
(B) Cryo-sections of pelleted fecal material ob-
tained from a dnKO mouse gavaged with WT
B. theta stained with mouse 6E9 antibody followed
by secondary goat anti-mouse IgG antibody con-
jugated to 18 nm colloidal gold. Image shows a
transverse cross-sectional view of B. theta parent
microbe with 6E9 staining on the bacterial mem-
brane and a budding OMV also with 6E9 staining.
Arrows, OMVs; arrowhead, B. theta. Bars, 100 nm
(A and C). Bar, 500 nm (B).
(D) Immunoblot of WT and DanSME B. theta
sonicates and OMV preps stained with the 6E9
antibody.
(E) Sulfatase activity (mol.min.mg1) of WT and
DanSME B. theta lysates and OMVs grown in
tryptone glucose yeast (TYG) and chondroitin
media. Control is TYG media alone. One repre-
sentative experiment shown of n = 2. See also
Figure S2 and Table S1.initiated in this model (Figure 1G; Figure S1E for additional con-
trols) (Bloom et al., 2011; Kang et al., 2008).
Host-Penetrant B. theta Antigen Localizes to OMVs with
Sulfatase Activity
With immunogold electron microscopy, we found that 6E9
recognized numerous 10- to 80-nm vesicles that were not
directly associated with B. theta (Figure 2A; Figure S2A for the
isotype control). The size and shape of these vesicles were
consistent with expelled OMVs that are classically produced
by the physiological process of pinching off a portion of the outer
membrane of Gram-negative bacteria (Kulp and Kuehn, 2010).
Immunogold labeling of cryo-sectioned fecal pellets from
dnKO mice gavaged with WT B. theta revealed that both
B. theta and its OMVs had 6E9-positive membranes (Figure 2B).
Because we demonstrated that B. theta produced OMVs
in vivo, we next wanted to determine the molecular mechanism
by which the OMVs accessed the host. OMVs have multiple
properties that would facilitate passage through host barriers
including small size (Elhenawy et al., 2014), enzymes such as sul-
fatases and glycoside hydrolases (GHs) (Elhenawy et al., 2014)
that may assist in glycan breakdown, and the ability to be endo-
cytosed by host cells (Irving et al., 2014). Desulfation is neces-
sary for the degradation of sulfated mucin glycans, which are
abundant in the colon. Of the nearly 5,000 genes present in the
B. theta genome, 28 of these genes encode sulfatases (Benjdia
et al., 2011). Thus, we hypothesized that the sulfatase activity
of B. theta may be important for the development of colitis in
dnKO mice.674 Cell Host & Microbe 17, 672–680, May 13, 2015 ª2015 Elsevier Inc.Fortuitously, a single gene in B. theta,
the anaerobic sulfatase maturating
enzyme (anSME) gene, is required for
post-translational activation of all 28 of
B. theta’s sulfatase enzymes (Berteau
et al., 2006). An engineered mutant strainof B. theta (DanSME strain) abrogates sulfatase activity (Benjdia
et al., 2011). The DanSME strain produced 6E9-positive OMVs
thatare similar toWTB. thetaOMVs inappearance (Figure2C;Fig-
ure S2B for isotype control) and concentration (Figures S1D and
S2C) (Chutkan et al., 2013). 6E9 also recognized a single 19-kD
Ag in OMVs from both strains (Figure 2D; see Figure S2D for addi-
tional controls). Immunoprecipitation followed bymass spectros-
copy analyses showed this protein was homologous to a pre-
dicted membrane protein, BT3901a (Figure S2E), that is widely
conserved in Bacteroides and highly expressed by B. theta both
in vivo and in vitro (Sonnenburg et al., 2005). BT3901a was
confirmed as the 6E9 antigen on an immunoblot comparing WT
B. theta and a BT3901a expressing E. coli (Figure S2F). As ex-
pected, theDanSMEstrainofB. thetashowed reducedgrowthus-
ing a sole energy source of gastric mucinO-glycans (Figure S2G)
that contained sulfated glycan structures (Table S1). Also, WT
B. thetaOMVs, but notDanSMEOMVs, contained detectable sul-
fatase activity when comparing equivalent amounts of protein
(Figure 2E; Figure S2H for bacterial comparisons).
In addition to this in vitro validation ofB. theta anSME function,
we next determined the feasibility of testing its function
in vivo. First, we examined the populations of Lactobacillus,
Enterococcaceae, and Lachnospiraceae/Ruminococcaceae via
16 s qPCR (Bloom et al., 2011) in six different groups: both
dnKO and IL10rb+/ mice gavaged with either PBS, WT
B. theta, or the DanSME strain of B. theta. No significant differ-
ences were noted in levels of any of these families between any
groups (Figures S2I–S2L). Second, B. theta sulfatase genes are
found within PULs that also encode GHs and other enzymes
Figure 3. The B. theta anSME Gene Is Necessary and Sufficient for Causing Colitis in dnKO Mice
(A) H&E-stained rectal sections from dnKO and littermate controls (IL10rb+/) 3 weeks after gavage with B. theta strains or PBS. dnKOmice were gavaged with
PBS (A1), WT B. theta (A3), DanSME (A4), and DanSME::anSME (A5), and a littermate control (IL10rb+/) was gavaged with WT B. theta (A2). For each low-power
image (1003) shown per group, a high-power image (4003) is included (boxed region adjacent to the low-power image). Bars, 200 mm for 1003 images. Bars,
30 mm for 4003 images.
(B and C) Graphs of average (B) crypts per 4003 field (0.55 mm) and (C) M-phase cells per 100 crypts are shown for different groups of gavaged dnKO
mice ± SEM.
(D) Graph of colonization at day 4 of dnKOmice and littermate control by B. theta strains via qPCR ± SEM. One-way ANOVA analysis: (B) F = 15.70, p < 0.0001,
nR 7 per group; (C) F = 21.79, p < 0.0001, nR 7 per group; (D) F = 116.4, p < 0.0001, nR 9 per group. Means with different letters are significantly different by
Tukey’s multiple comparisons test. See also Figure S3.involved in glycan degradation (Benjdia et al., 2011; Martens
et al., 2008). Because previous transcriptional studies of
B. theta were isolated to the mouse cecum and revealed low
expression of many sulfatase-containing PULs (Sonnenburg
et al., 2005), we confirmed that multiple B. theta sulfatase-con-
taining PULs were highly expressed in the distal colon (Figures
S3A–S3K). Also, because germ-free mice produce varying
amounts of sulfated mucin glycans in different regions of the co-
lon (Holme´n Larsson et al., 2013), we measured the thickness of
the inner sulfated mucus layer, which is Alcian blue positive at
pH = 1 (Lev and Spicer, 1964), in the distal colons of dnKO and
control IL10rb+/ mice (Figures S3L–S3R). All groups showed
similar thickness regardless of genotype or gavage inoculum
(Figures S3L–S3R).Cell HThe B. theta anSME Gene Is Necessary for Causing
Colitis in dnKO Mice
To determine if the anSME gene was required for B. theta’s coli-
togenic potential, we pre-treated dnKO and littermate controls
(IL10rb+/) with antibiotics for 3 weeks beginning at weaning as
previously described (Kang et al., 2008). We gavaged the mice
with DanSME mutant and WT B. theta strains 2 days after the
cessation of antibiotics and performed analysis 3 weeks there-
after. ComparedwithWTB. theta, theDanSMEstrain was unable
to elicit disease in dnKO mice as determined by histologic anal-
ysis of the colons (Figure 3A; Figure S3S for additional controls)
and quantification of crypt loss and epithelial hyperproliferation
(Figures 3B and 3C). As a control, when the DanSME B. theta
mutant was genetically complemented (DanSME::anSME), itost & Microbe 17, 672–680, May 13, 2015 ª2015 Elsevier Inc. 675
stimulated colitis similarly to the WT parent strain (Figures 3A–
3C). All B. theta strains colonized control and dnKO mice to
similar levels demonstrating that the observed colitogenic differ-
encesbetweenWTB. thetaand theDanSMEstrainswere not due
to quantitative differences in overall colonization (Figure 3D; Fig-
ures S3T, S3U, and S1D for additional controls). These data
support a role for bacterial sulfatases in B. theta’s colitogenic
potential.
OMVs Gain Access to Host Immune Cells in
B. theta-Colonized dnKOMice
We next tested if B. theta’s OMVs accessed host immune cells
in a sulfatase-dependent manner. Immunogold localization in
dnKOmice gavaged with WT B. theta showed 6E9-positive ves-
icles in mesenchymal cells that were morphologically consistent
with macrophages (Figures 4A and S4A–S4D). Then, to deter-
mine if OMVs required anSME to activate macrophages in the
absence of the mucus barrier, we incubated bone marrow mac-
rophages from dnKOmicewithOMVs fromeitherWT orDanSME
B. theta strains in vitro and found that OMVs from both strains
were internalized by these cells (Figures 4B, 4C, and S4E). As ex-
pected, macrophages from dnKOmice were more potently acti-
vated by anOMVstimuluswhen compared tomacrophages from
WT mice. However, OMVs from either bacterial strain were
equally able to elicit TNFa production from either macrophage
(Figure 4D). To determine the production of inflammatory modu-
lators by colonicmacrophages exposed in vivo toB. theta,we ex-
tracted colonic macrophages after gavage and then analyzed
gene expression. mRNA for Ptgs2 (a.k.a. Cox-2), TNFa, and
IL1-b were all significantly enriched in dnKO mice gavaged with
WT B. theta as compared to PBS and DanSME B. theta groups
(Figures S4F–S4H). Lastly, we performed double-label immuno-
fluorescence using 6E9 and F4/80 on dnKO mice gavaged with
WT B. theta. In these mice, we readily identified macrophages
that were 6E9 positive (Figures 4E and 4F). In contrast, in dnKOs
gavaged with DanSME B. theta, we rarely observed macro-
phages with 6E9 staining (Figures 4E and 4F). Additionally, we
performed double-label immunofluorescence using 6E9 and
CD11c on colonic sections of dnKOs gavaged with WT B. theta
and did not see any co-localization, suggesting these cells are
not dendritic cells. Together, these data show that only WT
B. theta OMVs can efficiently access mucosal macrophages
in vivo and suggest that B. theta accesses and activates the
host immune system in a sulfatase-dependent manner.
DISCUSSION
In this study, we showed that antigen from B. theta, a symbiotic
bacterium, localizes to the mucosa of a host that is genetically
susceptible to the development of colitis. We also determined
that B. theta’s anSME gene, which activates all of its sulfatases,
is necessary and sufficient for B. theta’s colitogenic behavior in
dnKOmice. Furthermore, we found that B. thetaOMVs localized
to host immune cells in vivo in a sulfatase-dependent manner.
Taken together, these results suggest that B. theta OMVs can
access the host’s immune cells in a sulfatase-dependent
fashion.
OMVs are pinched off fragments of the outer membrane and
periplasm of Gram-negative bacteria such as B. theta that are676 Cell Host & Microbe 17, 672–680, May 13, 2015 ª2015 Elsevier I20–250 nm in diameter (Kulp and Kuehn, 2010). Most studies
of OMVs to date have been performed using E. coli and Pseudo-
monas, which are relatively poor producers of OMVs as
evidenced by the fact that OMVs make up < 1% of the outer
membrane material in bacterial cultures (Bauman and Kuehn,
2006; Gankema et al., 1980). In contrast, B. theta is very efficient
in producingOMVs,making it an ideal model organism for further
studies (Elhenawy et al., 2014). OMVs have three general fea-
tures that highlight B. theta’s mechanism of access. First,
OMVs enable bacterial products to spread to locations that are
inaccessible to bacteria (Kulp and Kuehn, 2010). Second,
OMVs can be readily engulfed by host cells (Irving et al., 2014).
Third, OMVs contain a variety of functional bacterial products
including protein toxins, adhesins, and enzymes (Elhenawy
et al., 2014; Ellis and Kuehn, 2010). Specifically, B. theta pro-
duces a variety of enzymes that degrade host-derived carbohy-
drates (Elhenawy et al., 2014; Martens et al., 2008, 2009), and
some of these enzymes have recently been shown to be con-
tained in OMVs produced by this species (Elhenawy et al.,
2014). These properties of OMVs likely contribute to the ability
of B. theta OMVs to access the host’s immune cells.
OMVs are an obvious candidate for mediating microbial-host
interactions of certain symbiotic families. The challenge is how
to visualize the localization of parent bacteria and their specific
OMVswith respect to the host. For the parent microbe, a number
of tools exist for denoting localization including 16S DNA
probes (Swidsinski et al., 2005) and antibodies (Round et al.,
2011). However, there are few reagents to determine OMV local-
ization. The monoclonal antibodies described in this study,
3H2 and 6E9, are efficient and specific to Bacteroides species
and their OMVs, respectively. We anticipate that these reagents
will be valuable tools in further studies of B. theta-host
interactions.
OMVs can be taken up by a variety of host cells (Irving et al.,
2014). In our study, we showed that F4/80-positive, CD11c-
negative immune cells, consistent with macrophages, engulfed
B. theta’s OMVs. The gastrointestinal tract contains a high num-
ber of macrophages with a large proportion in the colon (Hume
et al., 1984; Lee et al., 1985). Intestinal macrophages typically
reside in the lamina propria adjacent to the base of crypts
(Hume et al., 1984). Interestingly, WT macrophages have been
proposed to lack pro-inflammatory responses when primed by
bacteria or their products (Bain et al., 2013; Smythies et al.,
2005). In contrast, it has been suggested that macrophages
in IL10RII-deficient mice fail to respond to tolerogenic signals
and become pro-inflammatory and potentially drive colitis
(Shouval et al., 2014). Future studies are necessary to better un-
derstand how resident macrophages are involved in inflamma-
tory diseases.
It is possible that B. theta sulfatases may be involved in
disease in genetically susceptible human hosts. Normally,
gastrointestinal mucus acts as a protective barrier, lubricant,
and bacterial habitat (Johansson et al., 2008). Mucin glycans
are protected from enzymatic breakdown by sulfate, sialic
acid, and ester modifications (Mian et al., 1979; Podolsky and Is-
selbacher, 1983; Tsai et al., 1992). Clinical studies of patients
with inflammatory bowel disease suggest that alterations in
sulfatase activity may be important in this disease. For example,
human fecal samples from IBD patients have elevated sulfatasenc.
Figure 4. OMVs Gain Access to Host Mac-
rophages in B. theta-Colonized dnKO Mice
(A) TEM image of 6E9-positive vesicle located
within a cell consistent with a macrophage in the
colonic mesenchyme of a WT B. theta-gavaged
dnKO mouse labeled with 6E9 mAb/goat anti-
mouse IgG antibody conjugated to 18 nm colloidal
gold. Bar, 100 nm.
(B) Co-localization of macrophages (CFSE, green)
derived from dnKOmice cultured with OMVs from
WT B. theta (Dil Vybrant dye, red). Bar, 50 mm. Bar,
5 mm (inset).
(C) Graph of the percent of CFSE+ macrophages
that co-localized with OMVs ± SEM. Unstimulated
macrophages from IL10rb+/ and dnKOmicewere
used as a control.
(D) Concentration of TNF-a (pg/ml) in the macro-
phage supernatant from IL10rb+/ or dnKO mice
cultured with OMVs from WT or DanSME
B. theta ± SEM.
(E) Staining of colonic mucosa from dnKOs gav-
aged with WT or DanSME B. theta with F4/80
(green) and 6E9 (red) antibodies. White dashed
lines, outlined crypts. Bar, 20 mm. Bar, 2.5 mm
(inset).
(F) Graph of percentage of double-positive F4/80+
and 6E9+ cells per crypt-associated mesen-
chyme in dnKO gavaged with PBS or B. theta
strains ± SEM. One-way ANOVA analysis: (C)
F = 10.65, p < 0.0001, n = 4 per group; (D)
F = 96.11, p < 0.0001, n = 4 per group; (F) F = 5.86,
p = 0.01, n R 6 per group. Means with different
letters are significantly different by Tukey’s multi-
ple comparisons test. See also Figure S4.
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activity (Corfield et al., 1992). Also, colonic mucin in ulcerative
colitis patients was shown to be degraded much more quickly
than normal mucin (Corfield et al., 1996). Thus, the findings of
our study emphasize how B. theta sulfatases may play a role in
inflammatory diseases and have the potential as targets for
drug research.
In conclusion, this work has opened up several avenues of
research into microbial access to the host immune system. First,
we have shown OMVs to be a mode by which bacteria access
the mucosa of a genetically susceptible host. Second, we have
introduced antibodies that can identify Bacteroides in situ. Third,
we have given credence to the idea that macrophages may be
critical in the development of inflammatory diseases in a genet-
ically susceptible host. Lastly, we have revealed a new potential
microbial drug target for inflammatory intestinal diseases, (i.e.,
anSME), which is present in most anaerobic gut bacteria.
EXPERIMENTAL PROCEDURES
For more details, please see Supplemental Experimental Procedures.
Mice
All experimental procedures were performed under approval by Washington
University’s Animal Studies Committee. Il10r2+/ and dnKO mice were co-
housed in an enhanced specific pathogen-free facility. Antibiotic treatment
with ciprofloxacin and metronidazole began at weaning.
Anti-B. theta Monoclonal Antibody Generation
C57BL/6 mice were immunized with killed B. theta (BT5482) and boosted, and
then splenic B cells were fused with P3Ag8.6.5.3 myeloma cells to create hy-
bridomas (Kearney et al., 1979). Themonoclonal antibodies were fluorescently
labeled with Alexa dyes.
Tissue Harvest, Fixation, and Preparation for Histology
Mouse tissues were fixed in methacarn, rinsed in methanol and ethanol, and
then stained with H&E and Alcian blue (pH 1.0).
Immunofluorescence Analysis
The 3H2 mAbs were directly conjugated to Alexa 647, and the 6E9 mAbs to
Alexa 594. The M.O.M. Kit was the blocking agent for 3H2 staining, and the
SNIPER for 6E9.
B. theta ELISA
B. theta were grown to log phase, then fixed in methacarn. Immulon 2 plates
were coated with poly L-lysine. Plates were coated with dilutions of fixed bac-
teria O/N at 4C. Plates were washed, blocked, and incubated. The ELISA was
developed with biotin-goat anti-mouse IgG followed by streptavidin peroxi-
dase and 1-Step Ultra TMB-ELISA.
Preparation of OMVs
B. thetaOMVs were purified with multiple rounds of centrifugation and filtering
(Chutkan et al., 2013).
Immunogold Labeling
Samples were allowed to absorb onto formvar/carbon-coated copper grids,
washed in dH2O, and stained with 1% aqueous uranyl acetate. Samples
were viewed on a JEOL 1200EX transmission electron equipped with an
8 megapixel digital camera (Advanced Microscopy Techniques).
Immunoblots for B. theta Antigen
Bacteria or OMVs were resuspended in PBS and sonicated. Samples were
loaded on gels for SDS-PAGE and western blotting using the Amersham
ECL Prime Western Blotting Detection Reagent following the manufacturer’s
instructions. Primary antibody 6E9 was used at a 1:5,000 dilution, and HRP
goat anti-mouse IgG was used at 1:3,000.678 Cell Host & Microbe 17, 672–680, May 13, 2015 ª2015 Elsevier ISulfatase Assay
A sulfatase assay was performed (Benjdia et al., 2011). Briefly, sulfatase activ-
ity was measured at 25C in 600-ml mixture of 10 mM of the substrate p-nitro-
phenyl sulfate. One unit of activity was defined as the release of 1 mmol of
product per minute per mg of protein.
Development of Bacterial B. theta Mutants
The B. theta strain VPI-5482/ATCC 29148 was manipulated for generation of
all mutants. Genetic deletion of the B. theta anSME gene was performed using
allelic exchange (Benjdia et al., 2011; Cameron et al., 2014).
Colitis Experiments
dnKO mice and littermate controls (IL10rb+/) were given antibiotics for
3 weeks after weaning and then taken off antibiotics for 2 days prior to gavage
and sacrificed at 21 days (Bloom et al., 2011).
In Vitro Macrophage Assays
Bone marrow cells were isolated from dnKO or Il10r2+/ littermate con-
trols and cultured in M-CSF (Hume et al., 1985). Macrophages were
co-cultured with purified OMVs from either WT B. theta or DanSME. Su-
pernatants were collected and assayed for the concentration of TNF-a by
ELISA.
Statistical Analysis
Statistical analysis was performed using Prism v3.02 and v5.01 (GraphPad
Software). Significance was determined with one-way ANOVA and defined
as p < 0.05.
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